Synartro AB
556866-4220ActiveDeveloping sustained local injection treatments for osteoarthritis pain relief.
Oversikt
- 1–4
- Ansatte
- ≤1t SEK
- Omsetning
- 2011
- Grunnlagt
Nøkkelbeslutningstakere
Magnus Hurst
CFO & acting CEO
Antonio Bermejo Gómez
Chief Development Officer
Mats Persson
Board Member
Maria Nyhage
Board Member
+2 flere kontakter i Funnelfeedr
Beskrivelse
Synartro AB is a clinical stage Swedish life science company focused on developing novel local injection treatments for osteoarthritis (OA). Their core innovation lies in a patented technology that chemically binds existing, proven drugs to a base compound. This process enables sustained drug releas...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556866422001
Beslutningstakere
6 kontakter i FunnelfeedrMagnus Hurst
CFO & acting CEO
Antonio Bermejo Gómez
Chief Development Officer
Mats Persson
Board Member
Maria Nyhage
Board Member
Fredrik Lehmann
Founder & Chairman
Andre kontakter
Dr. Ali Mobasheri
Scientific Advisor
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrStayble Therapeutics AB
5–9 ansatteDeveloping an injection treatment for pain caused by disc herniation.
Pharmnovo Aktiebolag
1–4 ansatteDeveloping non-addictive delta opioid receptor agonists for neuropathic pain.
Xintela AB
10–19 ansatteDeveloping stem cell and targeted cancer therapies for unmet needs.
REGENARTI AS
Norwegian company developing peptide-enhanced gel for joint repair.
SynAct Pharma AB
5–9 ansatteClinical-stage biotech resolving inflammation via novel oral therapies.
Utforsk mer
Spørsmål om Synartro AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo